Board – members

Erik van den Berg

CEO, AM-Pharma  Erik brings over 25 years’ experience and serves as CEO at AM-Pharma since 2011.  Erik is Chairman of Step Pharma and co-founder and previous (executive) Chairman of Lava Therapeutics (NASDAQ: LVTX), co-founder and previous (executive) Chairman of Heatmatrix Group (sold to BosNieuwkerk) and was board member of Lead

Read More >

Fraser Murray, PhD

Scientific Advisor, Advent Life Sciences   Fraser is a neuropharmacologist with almost 30 years of drug discovery and early development experience across a range of therapeutic areas, including neurodegeneration, psychiatry, inflammation, gastrointestinal and dermatology. He has a wide C-suite experience in multiple biotech startups and held leadership roles at Shire, AstraZeneca,

Read More >

Benoit Barteau, PhD

Investment Director, Life Sciences, Bpifrance Investissements  Since 2014 at Bpifrance Investissements, Benoit has been involved in a dozen investment deals and current board member positions include Alentis, Dynacure, Igyxos, Meiogenix and BrainEver. Prior to this, he gained experience in various biotech roles, co-discovered a vaccine candidate, and developed an antibody

Read More >

Alain Huriez, MD

Chairman and Managing Partner, AdBio Partners  Alain brings over 30 years of experience in life sciences and finance. He started his career as a General Practitioner (GP) and then spent ten years in biotechnology drug development and regulatory strategy as vice president of Quintiles (IQVIA) Europe. Prior to joining VC firm Advent Life Sciences

Read More >